Dynamic regulation of proinflammatory cytokines

Advances in Experimental Medicine and Biology

Volumn 461, Issue , 1999, Pages 153-178

  Watkins, L R ^a   Nguyen, K T ^a   Lee, J E ^a   Maier, S F ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

CONFERENCE PAPER; CYTOKINE PRODUCTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; RNA TRANSLATION; STRESS; TRANSCRIPTION REGULATION;

EID: 0033282349     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-585-37970-8_10     Document Type: Conference Paper

References (194)

1. The effect of stress in vivo on the function of mouse macrophages in vitro
2. Regulation of interleukin (IL)-1 beta gene transcription induced by IL-1 beta in rheumatoid synovial fibroblast-like cells, E11, transformed with simian virus 40 large T antigen
3. Quantitative analysis of cytokine mRNA expression in peripheral blood mononuclear cells following treatment with interleukin-2
4. Effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells
5. Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes
6. Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: Mediation by decreased mRNA stability
7. Stress-induced murine abortion associated with substance P-dependent alteration in cytokines in maternal uterine decidua
8. Soluble receptors neutralizing TNF-alpha and IL-1 block stress-triggered murine abortion
9. Prior exercise suppresses the plasma tumor necrosis factor response to bacterial lipopolysaccharide
10. Secretion of IL-1: Role of protein kinase C
11. Substance P primes murine peritoneal macrophages for an augmented proinflammatory cytokine response to lipopolysaccharide
12. Effect of microgravity modeling on interferon and interleukin responses in the rat
13. The effect of strenuous exercise, calorie deficiency and sleep deprivation on white blood cells, plasma immunoglobulins and cytokines
14. Regulatory effect of recombinant interleukin (IL)3 and IL4 on cytokine gene expression of bone marrow and peripheral blood mononuclear cells
15. Blood mononuclear cells mobilization and cytokines secretion during prolonged exercises
16. Antagonist effect of RU 486 on transcription of glucocorticoid-regulated genes
17. Transcriptional repression of the prointerleukin 1β gene by heat shock factor 1
18. Mild endotoxaemia and the inflammatory response induced by a marathon race
19. Physiological mechanisms contributing to increased interleukin-1 secretion
20. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators
21. Some aspects of the acute phase response after a marathon race, and the effects of glutamine supplementation
22. Substance P and stress-induced changes in macrophages
23. Cyclic AMP signaling pathways are important in IL-1 beta transcriptional regulation
24. Modulation of cytokine production by transforming growth factor-beta
25. Immunosuppression in mice induced by cold water stress
26. Dissociation of IL-1β synthesis and secretion in human blood monocytes stimulated with bacterial cell wall products
27. Selective inhibition of interleukin-1 beta gene expression in activated RAW 264.7 macrophages by interferon-gamma
28. NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site
29. Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin-1, and urokinase genes, which are controlled by short-lived repressors
30. Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4
31. Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells
32. The immediate early genes of human cytomegalovirus require only proximal promoter elements to upregulate expression of interleukin-1 beta
33. Stress-induced changes in immune function are associated with increased production of an interleukin-1-like factor in young domestic fowl
34. Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF-alpha) production in humans: High sensitivity of TNF-alpha and resistance of IL-6
35. Induction of plasma interleukin-6 by circulating adrenaline in the rat
36. Dissociation of transcription from translation of human IL-1 beta: Induction of steady state mRNA by adherence or recombinant C5a in the absence of translation
37. Cytokine production and lymphocyte transformation during stress
38. Neuroendocrine regulation of cytokine production during experimental influenza viral infection: Effects of restraint stress-induced elevation in endogenous corticosterone
39. IL-1 expression in human monocytes is transcriptionally and posttranscriptionally regulated by IL-4
40. Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production
41. Plasma elastase-alpha 1-antitrypsin, neopterin, tumor necrosis factor, and soluble interleukin-2 receptor after prolonged exercise
42. Effects of psychological stress on plasma interleukins-1 beta and 6, C-reactive protein, tumour necrosis factor-alpha, anti-diuretic hormone, and serum cortisol
43. Fibroblast interleukin-1 beta: Synergistic stimulation by recombinant interleukin-1 and tumor necrosis factor and posttranscriptional regulation
44. Effect of physical exercise on cytokines and lymphocyte subpopulations in human peripheral blood
45. Short-term changes in the immune system of elite swimmers under competition conditions. Different immunomodulation induced by various types of sport
46. The interleukin-1 receptor antagonist and its delivery by gene transfer
47. Role of the hypothalamus-pituitary-adrenal axis in the regulation of TNF production in mice. Effect of stress and inhibition of endogenous glucocorticoids
48. Review: Transcriptional and post-transcriptional regulation of interleukin-1 gene expression
49. Human pro-IL-1 beta gene expression in monocytic cells is regulated by two distinct pathways
50. Transcriptional and post-transcriptional regulation of GM-CSF-induced IL-1 beta gene expression in PMN
51. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages
52. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein
53. Interleukin-1 receptor accessory protein transcripts in the brain and spleen: Kinetics after peripheral administration of bacterial lipopolysaccharide in mice
54. Circulating levels of peripheral blood leucocytes and cytokines following competitive cycling
55. Central nervous system IL-1 beta system and neuropeptide Y mRNAs during IL-1 beta-induced anorexia in rats
56. Recombinant human C5a induces transcription but not translation of interleukin-1 beta mRNA in human monocytes
57. Stress depresses interferon production by leukocytes concomitant with a decrease in natural killer cell activity
58. Tumor necrosis factor increases stability of interleukin-1 mRNA by activating protein kinase C
59. Stress downregulates lipopolysaccharide-induced expression of proinflammatory cytokines in the spleen, pituitary, and brain of mice
60. Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex
61. ATP induces the release of IL-1 from LPS-primed cells in vivo
62. Effect of physical exercise on in vitro production of interleukin-1, interleukin-6, tumour necrosis factor-alpha, interleukin-2, and interferon-gamma
63. Processing of precursor interleukin-1 beta and inflammatory disease
64. Macrophage and monocyte IL1-beta regulation differs at multiple sites. Messenger RNA expression, translation, and post-translational processing
65. Modulation of interleukin-1 and tumor necrosis factor expression by beta-adrenergic agonists in mouse ameboid microglial cells
66. Characterization of a functional NF-kappa B site in the human interleukin-1 beta promoter: Evidence for a positive autoregulatory loop
67. Interaction between cortisol and tumour necrosis factor with concurrent resistance and endurance training
68. Recruitment of IRAK to the interleukin-1 receptor complex requires interleukin-1 receptor accessory protein
69. The functional importance of a cap site-proximal region of the human prointerleukin-1 beta gene is defined by viral protein transactivation
70. Elevation of cyclic adenosine monophosphate levels independently down regulates IL-1, IL-2, and IL-2 receptor (CD25) synthesis
71. Immune system of cold-exposed and cold-adapted humans
72. Intracellular IL-1 receptor antagonist promoter: Cell type-specific and inducible regulatory regions
73. Differential regulation of IL-1 and IL-1 receptor antagonist in HaCaT keratinocytes by tumor necrosis factor-alpha and transforming growth factor-beta 1
74. Tumor necrosis factor-alpha and tumor necrosis factor-beta (lymphotoxin) stimulate the production of granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and IL-1 in vivo
75. Cloning, tissue expression, and regulation of rat interleukin-1 beta converting enzyme
76. Sickness behavior as a new target for drug development
77. Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms
78. The adrenergic regulation of interleukin production by bone marrow cells during immobilization stress
79. Chronic stress alters the immune response to influenza virus vaccine in older adults
80. Slowing of wound healing by psychological stress
81. Protein synthesis-dependent induction of interleukin-1 beta by lipopolysaccharide is inhibited by dexamethasone via mRNA destabilization in human astroglial cells
82. Immobilization stress increases hepatic IL-6 expression in mice
83. Effect of heat stress on LPS-induced fever and tumor necrosis factor
84. Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate
85. Initiation of acute phase response and synthesis of cytokines
86. Effects of antiorthostatic suspension and corticosterone on macrophage and spleen cell function
87. A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling
88. Altered interleukin-1 production in mice exposed to rotation stress
89. Interleukin-1 and defensins in thermoregulation, stress, and immunity
90. Cross-linking of intercellular adhesion molecule 1 (CD54) induces AP-1 activation and IL-1beta transcription
91. Evidence for protein kinase C pathway in the response of human peripheral blood mononuclear cells to cholera toxin
92. Translational blockade imposed by cytokine-derived UA-rich sequences
93. Suppression of lymphocyte mitogenesis in different rat strains exposed to footshock during early diurnal and nocturnal time periods
94. Changes in blood cell response following strenuous physical exercise
95. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro II. Inhibitation of IL-1 beta production from ATP-treated monocytes and macrophages
96. Human monocyte ATP-induced IL-1 beta posttranslational processing is a dynamic process dependent on in vitro growth conditions
97. Effects of lipopolysaccharide and glucocorticoids on expression of interleukin-1 beta converting enzyme in the pituitary and brain of mice
98. Constitutive activity of the murine IL-1 beta promoter is regulated by a transcriptional repressor
99. Glucocorticoids selectively inhibit the transcription of the interleukin-1 beta gene and decrease the stability of interleukin-1 beta mRNA
100. The effects of psychological stress on plasma interleukin-6 activity in rats
101. Corticosteroids induce intracellular interleukin-1 receptor antagonist type I expression by a human airway epithelial cell line
102. Extracellular release of the type I intracellutar IL-1 receptor antagonist from human airway epithelial cells: Differential effects of IL-4, IL-13, IFN-gamma, and corticosteroids
103. Effect of maximal physical exercise on T-lymphocyte subpopulations and on interleukin-1 (IL-1) and interleukin-2 (IL-2) production in vitro
104. Role of corticosterone in TNF and IL-6 production in isolated perfused rat liver
105. Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver
106. Rat homolog of mouse interleukin-1 receptor accessory protein: Cloning, localization, and modulation studies
107. A cyclic adenosine 3′,5′-monophosphate signal is required for the induction of IL-1 beta by TNF-alpha in human monocytes
108. Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL 1R-rp2)
109. Cytokines for psychologists: Implications of bi-directional immune-to-brain communication for understanding behavior, mood, and cognition
110. Cloning and characterization of a new isoform of the interleukin-1 receptor antagonist
111. Substance P stimulates IL-1 production by astrocytes via intracellular calcium
112. The effects of noise stress on leukocyte function in rats
113. Diet-dependent and diet-independent metabolic responses underlie growth stasis of pigs at weaning
114. Chronic restraint enhances interleukin-1-beta release in the basal state and after an endotoxin challenge, independently of adrenocorticotropin, and corticosterone release
115. The IL-1 beta converting enzyme as a therapeutic target
116. The metabolic stressor 2-deoxy-D-glucose (2-DG) enhances LPS-stimulated cytokine production in mice
117. Immobilization stress induces interleukin-1 beta mRNA in the rat hypothalamus
118. Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis
119. Rapid and specific conversion of precursor interleukin-1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase
120. Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cells
121. Induction by transforming growth factor-beta 1 of the interleukin-1 receptor antagonist and of its intracellular form in human polymorphonuclear cells
122. Effect of acute exhausting exercise on cytokine gene expression in men
123. Superinduction of NF-kappa B by actinomycin D and cycloheximide in epithelial cells
124. Exposure to acute stress induces brain interleukin-1 beta protein in the rat
125. The cytokine response to strenuous exercise
126. Ca2+ and calmodulin selectively regulate lipopolyysaccharide-inducible cytokine mRNA expression in murine peritoneal macrophages
127. cAMP differentially regulates expression of mRNA encoding IL-1 alpha and IL-1 beta in murine peritoneal macrophages
128. Possible involvement of adenosine 3′:5′-cyclic monophosphate and extracellular calcium ions in histamine stimulation of interleukin-1 release from macrophage-like P388D1 cells
129. Interleukin-1 beta (IL-1 beta) expression in human blood mononuclear phagocytes is differentially regulated by granulocyte-macrophage colony-stimulating factor (GM-CSF), M-CSF, and IL-3
130. Corticotropin-releasing hormone differentially modulates the interleukin-1 system according to the level of monocyte activation by endotoxin
131. Bradykinin stimulates NF-kappaB activation and interleukin-1 beta gene expression in cultured human fibroblasts
132. Exercise stimulates interleukin-6 secretion: Inhibition by glucocorticoids and correlation with catecholamines
133. IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP
134. Human monocyte interleukin-1 beta posttranslational processing. Evidence of a volume-regulated response
135. Tenidap and other anion transport inhibitors disrupt cytolytic T lymphocyte-mediated IL-1 beta post-translational processing
136. Acute stress affects cytokines and nitric oxide production by alveolar macrophages differently
137. Proinflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine
138. Effects of progressive resistance training on immune response in aging and chronic inflammation
139. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor
140. Expression of interleukin-1 receptor antagonist (IL-1ra) by human circulating polymorphonuclear cells
141. The type II "receptor" as a decoy target for interleukin-1 in polymorphonuclear leukocytes: Characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor
142. Low affinity binding of interleukin-1 beta and intracellular signaling via NF-kappa B identify Fit-1 as a distant member of the interleukin-1 receptor family
143. Effects of the stress response in septic rats and LPS-stimulated alveolar macrophages: Evidence for TNF-alpha posttranslational regulation
144. Release of cytokines by blood monocytes during strenuous exercise
145. Arachidonic acid mediates interleukin-1 and tumor necrosis factor-alpha-induced activation of the c-jun amino-terminal kinases in stromal cells
146. Ultraviolet light and osmotic stress: Activation of the JNK cascade through multiple growth facto and cytokine receptors
147. Reactive oxygen intermediates cause rapid release of the interleukin-1 decoy receptor from human myelomonocytic cells
148. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors
149. TGF-beta differentially modulates epidermal growth factor-mediated increases in leukemia-inhibitory factor, IL-6, IL-1 alpha, and IL-1 beta in human thymic epithelial cells
150. Systemic interleukin-1 alpha and interleukin-2 secretion in response to acute stress and to corticotropin-releasing hormone in humans
151. Synergism between protein-kinase C and cAMP-dependent pathways in the expression of the interleukin-1 beta gene is mediated via the activator-protein-1 (AP-1) enhancer activity
152. Regulation of interleukin-1 gene expression by protein kinase C and cyclic AMP
153. Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-alpha and IL-1 beta production by human monocytes
154. Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat
155. The influence of restraint stress on the expression of mRNAs for IL-6 and the IL-6 receptor in the hypothalamus and midbrain of the rat
156. The effect of gamma interferon on interleukin-1 release of human monocytes. Dependence on the activating agent and correlation to the mRNA levels
157. The interleukin-1 beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy
158. Transcription, translation and secretion of interleukin-1 and tumor necrosis factor: Effects of tebufelone, a dual cyclooxygenase/5-lipoxygenase inhibitor
159. Regulation of cytokine and growth factor gene expression in human bone marrow stromal cells transformed with simian virus 40
160. Cytokine immunoreactivity in plasma does not change after moderate endurance exercise
161. Differential regulation of interleukin-1 alpha and interleukin-1 beta mRNA expression in human monocytes: Evidence for protein kinase C-dependent and -independent pathways
162. Beta-adrenoceptor antagonists suppress elevation in body temperature and increase in plasma IL-6 in rats exposed to open field
163. Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorder
164. Activation of distinct protein kinase C isozymes by phorbol esters: Correlation with induction of interleukin-1 beta gene expression
165. Increased cyclic AMP levels enhance IL-1 alpha and IL-1 beta mRNA expression and protein production in human myelomonocytic cell lines and monocytes
166. IL-1 secretion by macrophages. Enhancement of IL-1 secretion and processing by calcium ionophores
167. Immobilization stress increases mRNA levels of interleukin-1 receptor antagonist in various rat brain regions
168. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor-alpha (TNF-alpha) translation: Glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK
169. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist
170. Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines
171. Regionally specific induction of ICE mRNA and enzyme activity in the rat brain and adrenal gland by LPS
172. Production of tumor necrosis factor-alpha, interleukin-1, and interleukin-6 in the perfused rat liver
173. Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin-1 beta gene
174. A novel STAT-like factor mediates lipopolysaccharide, interleukin-1 (IL-1), and IL-6 signaling and recognizes a gamma interferon activation site-like element in the IL-1β gene
175. Regulation of expression of human IL-1 alpha and IL-1 beta genes
176. Bicycle exercise enhances plasma IL-6 but does not change IL-1 alpha, IL-1 beta, IL-6, or TNF-alpha pre-mRNA in BMNC
177. Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-6 production in human whole blood
178. The relation among stress, adrenalin, interleukin-6, and acute phase proteins in the rat
179. Histamine enhances interleukin (IL)-1-induced IL-1 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. Comparison with IL-1 receptor antagonist
180. Substance P and keratinocyte activation markers: An in vitro approach
181. Cyclic adenosine monophosphate decreases the secretion, but not the cell-associated levels, of interleukin-1 beta in lipopolysaccharide-activated human monocytes
182. The IL-1 receptor accessory protein is responsible for the recruitment of the interleukin-1 receptor associated kinase to the IL-1/IL-1 receptor I complex
183. Glucocorticoids inhibit the production of IL-6 from monocytes, endothelial cells, and fibroblasts
184. The intracellular IL-1 receptor antagonist alters IL-1-inducible gene expression without blocking exogenous signaling by IL-1 beta
185. Co-expression of mRNA for type I and type II interleukin-1 receptors and the IL-1 receptor accessory protein correlates to IL-1 responsiveness
186. Inhibition of lipopolysaccharide-induced IL-1 beta transcription by cyclic adenosine monophosphate in human astrocytic cells
187. Regulation of levels of IL-1 mRNA in human fibroblasts
188. Inhibition of tumor necrosis factor-alpha and interleukin-1-beta production by beta-adrenoceptor agonists from lipopolysaccharide-stimulated human peripheral blood mononuclear cells
189. Stress, reactivity, and immune function in healthy men
190. A negative regulatory region containing a glucocorticosteroid response element (nGRE) in the human interleukin-1 beta gene
191. Regulation of the interleukin-1 beta (IL-1 beta) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL-6 motifs
192. Exposure to physical and psychological stressors elevates plasma interleukin-6: Relationship to the activation of hypothalamic-pituitary-adrenal axis
193. Endogenous substance P mediates cold water stress-induced increase in interleukin-6 secretion from peritoneal macrophages
194. Reduced cytokine levels and T-cell function in healthy males: Relation to individual differences in subclinical anxiety